Trial Profile
NCRN033 - Industry trial.
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2011
Price :
$35
*
At a glance
- Drugs Linifanib (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Apr 2009 Status changed from planning to suspended as reported by United Kingdom Clinical Research Network.
- 30 Jan 2009 New trial record